Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > re lower prescription prices

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Feb 26, 2021 10:48am

110 Views

Post# 32670594

RE:RE:re lower prescription prices

I think it goes without saying!!
I dont know how much of a discount but I have no doubt whatsoever that this is part of THTX marketing program ..

SPCEO1 wrote: Do we know for sure that this is something TH has intiated? Can we even tell how much of a discount this is from the info provided?

palinc2000 wrote: Paul is really serious about shaking things up